Skip to main content

Solésence Inc. Value Stock - Dividend - Research Selection

Nanophase technologies

ISIN: US6300791018 , WKN: 910885

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Nanophase Technologies Corporation develops and manufactures advanced materials and applications with an integrated nanomaterial and related technologies. It produces engineered nano and larger, and sub-micron materials for use in various markets, which comprise personal care, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and various surface finishing technologies. The company was founded in 1989 and is headquartered in Romeoville, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

2026-08-25
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.

Solesence, Inc. Common Stock Q2 2026 Earnings Call Summary

2026-08-20
Moby summary of Solesence, Inc. Common Stock's Q2 2026 earnings call

Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...

2026-08-20
Company projects $35 million in second-half revenue and expands into scalp care while navigating inventory costing issues.

Solésence Reports Second Quarter 2026 Financial Results

2026-08-19
Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically driven health care solutions across beauty and life science categories, today reported its financial results for the second quarter ended June 30, 2026. “In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Trans

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

2026-08-19
Solesence, Inc. (SLSN) Q2 2026 Earnings Call August 19, 2026 5:00 PM EDTCompany ParticipantsKevin Cureton - President, CEO & DirectorLaura Riffner -...

Solesence Reports Q2 2026 Results: Full Earnings Call Transcript

2026-08-19
Solesence (NASDAQ:SLSN) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data

Solesence Q2 Sales $15.332M Down From $20.359M YoY

2026-08-19
Solesence (NASDAQ:SLSN) reported $15.332 million in sales this quarter. This is a 24.69 percent decrease over sales of $20.359 million the same period last year.

Solésence Reschedules Second Quarter 2026 Conference Call to August 19

2026-08-10
ROMEOVILLE, Ill., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast. The additional time will allow the Company to complete its quarterly financial reporting and review process. The conference call and webcast will occur on Wednesday, August 19, 2026, at 5:00 p.m. ET. Second Quarter

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

2026-07-28
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date. Second Quarter 2026 Conference Call DetailsDate/Time: Tuesday, August 11, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin

SLSN Unveils Two Scalp Care Products Using Patented Technology

2026-07-14
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.